CATEGORIES
PRODUCT CATEGORIES
Strategic focus across high-value therapeutic areas
CNS
Dermatology
Gastrointestinal
Respiratory
Urology
Anti-Bacterials
Central Nervous System (CNS)
Neuragenix Pharma develops and manages Marketing Authorisations for CNS products addressing complex neurological and psychiatric conditions. Our approach prioritises robust clinical justification, regulatory clarity, and long-term compliance to ensure reliable access to essential therapies within the UK & EU markets.
Dermatology
Our dermatology portfolio focuses on value-driven treatments for chronic and acute skin conditions. We ensure regulatory submissions are aligned with current guidelines, labelling accuracy, and lifecycle sustainability—supporting safe, compliant, and commercially viable dermatological medicines.
Gastrointestinal (GI)
Neuragenix Pharma supports GI products designed to meet ongoing clinical demand and patient need. From dossier development to post-approval maintenance, we manage regulatory pathways that enable consistent market access while maintaining high standards of quality and compliance.
Urology
Our urology portfolio includes medicines targeting common and specialist urological conditions. We apply disciplined regulatory strategy and lifecycle oversight to ensure approvals are resilient, compliant, and aligned with long-term treatment needs across UK & EU healthcare systems.
Respiratory
Neuragenix Pharma manages respiratory products with a focus on regulatory robustness, patient safety, and continuity of supply. Our expertise ensures precise dossier positioning, accurate SmPC maintenance, and effective post-approval compliance in a highly scrutinised therapeutic area.
Anti-Bacterials
We prioritise antibacterial products that support public health needs and responsible antimicrobial stewardship. Our regulatory approach ensures scientifically sound submissions, compliance with evolving guidelines, and sustainable lifecycle management within the UK & EU regulatory environment.